Advances in the Diagnosis and Treatment of Urinary Tract Infection in the Elderly

doi:10.12114/j.issn.1007-9572.2019.07.024

Abstract

Abstract: Urinary tract infection（UTI） refers to the inflammatory response of tourothelium to the invasion of pathogenic bacteria，often accompanied by bacterial urine and pyuria.UTI in the elderly is generally divided into symptomatic and asymptomatic bacteriuria.As it often has no typical symptoms and signs，results of laboratory test，etiological examination and drug susceptibility testing should be taken into account when making a diagnosis or giving treatment guidance.Active and effective prevention，identification of atypical clinical manifestations，definite diagnosis，and rational use of antibiotics are the key to the management of UTI in the elderly.This article reviews the epidemiology and pathogens of UTI in the elderly，as well as the progress of diagnosis，treatment and prevention，in order to provide a reference for doctors to improve the treatment effect of UTI and the quality of life in the elderly.

Key words: Aged, Urinary tract infections, Bacteriuria, Review

摘要： 泌尿道感染（UTI）指尿路上皮对病原菌侵入导致的炎性反应，常伴有细菌尿和脓尿。老年UTI广义上分为症状性细菌尿、无症状性菌尿（ASB）。老年UTI常缺乏典型的症状及体征，需要结合实验室检查、病原学检查、药敏试验等进行诊断和指导治疗，积极有效的预防、鉴别不典型的临床表现、明确诊断、合理使用抗生素是老年UTI的治疗关键。本文对老年UTI的流行病学和病原学以及诊治、预防的进展进行综述，以期为广大医生提供参考，最终提高老年UTI治疗效果和老年人生活质量。

关键词: 老年人, 泌尿道感染, 细菌尿, 综述

HUI Miao,LI Yuehong. Advances in the Diagnosis and Treatment of Urinary Tract Infection in the Elderly　[J]. Chinese General Practice, 2019, 22(7): 869-872. DOI: 10.12114/j.issn.1007-9572.2019.07.024.
惠淼,李月红. 老年泌尿道感染诊治进展[J]. 中国全科医学, 2019, 22(7): 869-872. DOI: 10.12114/j.issn.1007-9572.2019.07.024.

References

［1］FOXMAN B，BROWN P.Epidemiology of urinary tract infections：transmission and risk factors，incidence，and costs［J］．Infect Dis Clin North Am，2003，17（2）：227-241.
［2］NICOLLE L E，BRADLEY S，COLGAN R，et al．Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults［J］．Clin Infect Dis，2005，40（5）：643-654．DOI：10.1086/427507.
［3］BETSCH B Y，EGGLI S，SIEBENROCK K A，et al．Treatment of joint prosthesis infection in accordance with current recommendations improves outcome［J］．Clin Infect Dis，2008，46（8）：1221-1226．DOI：10.1086/529436.
［4］O'FALLON E，SCHREIBER R，KANDEL R，et al．Multidrug-resistant gram-negative bacteria at a long-term care facility：assessment of residents，healthcare workers，and inanimate surfaces［J］．Infect Control Hosp Epidemiol，2009，30（12）：1172-1179．DOI：10.1086/648453.
［5］DANEMAN N，BRONSKILL S E，GRUNEIR A，et al．Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents［J］．JAMA Intern Med，2015，175（8）：1331-1339．DOI：10.1001/jamainternmed.2015.2770.
［6］LI D，WANG T，SHEN S，et al．Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors：a meta-analysis of randomized controlled trials［J］．Diabetes Obes Metab，2017，19（3）：348-355．DOI：10.1111/dom.12825.
［7］LITTLE P，MOORE M V，TURNER S，et al．Effectiveness of five different approaches in management of urinary tract infection：randomised controlled trial［J］．BMJ，2010，340：c199．DOI：10.1136/bmj.c199.
［8］LOB S H，NICOLLE L E，HOBAN D J，et al．Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States，SMART 2010—2014［J］．Diagn Microbiol Infect Dis，2016，85（4）：459-465．DOI：10.1016/j.diagmicrobio.2016.04.022.
［9］THADEN J T，LEWIS S S，HAZEN K C，et al．Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals：a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States［J］．Infect Control Hosp Epidemiol，2014，35（8）：978-983．DOI：10.1086/677157.
［10］MEDIAVILLA J R，PATRAWALLA A，CHEN L，et al．Colistin- and carbapenem-resistant escherichia coli harboring mcr-1 and blaNDM-5，causing a complicated urinary tract infection in a patient from the United States［J］．MBio，2016，7（4）：e01191-16．DOI：10.1128/mBio.01191-16.
［11］PERON E P，HIRSCH A A，JURY L A，et al．Another setting for stewardship：high rate of unnecessary antimicrobial use in a veterans affairs long-term care facility［J］．J Am Geriatr Soc，2013，61（2）：289-290．DOI：10.1111/jgs.12099.
［12］CORTES-PENFIELD N W，TRAUTNER B W，JUMP R L P.Urinary tract infection and asymptomatic bacteriuria in older adults［J］．Infect Dis Clin North Am，2017，31（4）：673-688．DOI：10.1016/j.idc.2017.07.002.
［13］LEUCK A M，WRIGHT D，ELLINGSON L，et al．Complications of foley catheters：is infection the greatest risk?［J］．J Urol，2012，187（5）：1662-1666．DOI：10.1016/j.juro.2011.12.113.
［14］LO E，NICOLLE L E，COFFIN S E，et al．Strategies to prevent catheter-associated urinary tract infections in acute care hospitals：2014 update［J］．Infect Control Hosp Epidemiol，2014，35（suppl 2）：s32-47.
［15］尿路感染诊断与治疗中国专家共识编写组．尿路感染诊断与治疗中国专家共识（2015版）：尿路感染抗菌药物选择策略及特殊类型尿路感染的治疗建议［J］．中华泌尿外科杂志，2015，36（4）：245-248.
Chinese Expert Consensus Writing Group for Diagnosis and Treatment of Urinary Tract Infection．Chinese expert consensus on diagnosis and treatment of urinary tract infection （2015 edition）：antibacterial drug selection strategy for urinary tract infection and treatment recommendations for special types of urinary tract infection［J］．Chin J Urol，2015，36（4）：245-248.
［16］SINGH N，GANDHI S，MCARTHUR E，et al．Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women［J］．CMAJ，2015，187（9）：648-656．DOI：10.1503/cmaj.150067.
［17］American Geriatrics Society 2015 Beers Criteria Update Expert Panel.American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults［J］．J Am Geriatr Soc，2015，63（11）：2227-2246．DOI：10.1111/jgs.13702.
［18］OPLINGER M，ANDREWS C O.Nitrofurantoin contraindication in patients with a creatinine clearance below 60 ml/min：looking for the evidence［J］．Ann Pharmacother，2013，47（1）：106-111．DOI：10.1345/aph.1R352.
［19］FALAGAS M E，VOULOUMANOU E K，TOGIAS A G，et al．Fosfomycin versus other antibiotics for the treatment of cystitis：a meta-analysis of randomized controlled trials［J］．J Antimicrob Chemother，2010，65（9）：1862-1877．DOI：10.1093/jac/dkq237.
［20］HOOTON T M.Clinical practice.Uncomplicated urinary tract infection［J］．N Engl J Med，2012，366（11）：1028-1037．DOI：10.1056/NEJMcp1104429.
［21］GRABE M J.Re：treatment duration of febrile urinary tract infection：a pragmatic randomized，double-blind，placebo-controlled non-inferiority trial in men and women［J］．Eur Urol，2017，72（4）：652．DOI：10.1186/s12916-017-0835-3.
［22］TARIQ R，PARDI D S，TOSH P K，et al．Fecal microbiota transplantation for recurrent clostridium difficile infection reduces recurrent urinary tract infection frequency［J］．Clin Infect Dis，2017，65（10）：1745-1747．DOI：10.1093/cid/cix618.
［23］DULL R B，FRIEDMAN S K，RISOLDI Z M，et al．Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults：a systematic review［J］．Pharmacotherapy，2014，34（9）：941-960．DOI：10.1002/phar.1437.
［24］SMAILL F M，VAZQUEZ J C.Antibiotics for asymptomatic bacteriuria in pregnancy［J］．Cochrane Database Syst Rev，2015，8：CD000490．DOI：10.1002/14651858.
［25］KOVES B，CAI T，VEERATTERAPILLAY R，et al．Benefits and harms of treatment of asymptomatic bacteriuria：a systematic review and meta-analysis by the European Association of Urology Urological Infection Guidelines Panel［J］．Eur Urol，2017，72（6）：865-868．DOI：10.1016/j.eururo.2017.07.014.
［26］RAZ R，SCHILLER D，NICOLLE L E.Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection［J］．J Urol，2000，164（4）：1254-1258.
［27］MARSCHALL J，CARPENTER C R，FOWLER S，et al．Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter：meta-analysis［J］．BMJ，2013，346：f3147．DOI：10.1136/bmj.f3147.
［28］BIANCO L，PERRELLI E，TOWLE V，et al．Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents［J］．J Am Geriatr Soc，2012，60（6）：1180-1181．DOI：10.1111/j.1532-5415.2012.03976.x.

[1]	TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860.
[2]	WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846.
[3]	XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822.
[4]	LI Ling, LI Yaping, QIAN Shixing, NIE Jing, LU Chunhua, LI Xia. Research on Influencing Factors and Risk Prediction of Cognitive Function in Community-dwelling Middle-aged and Elderly People [J]. Chinese General Practice, 2025, 28(30): 3773-3778.
[5]	ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472.
[6]	HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344.
[7]	YU Wenhua, LI Jianguo, DUAN Wenyan, GAO Xuyan, LI Xiaxia, ZHANG Zilong, ZHANG Li, MA Lina. Reliability and Validity of the Function Impairment Screening Tool among Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(24): 3000-3004.
[8]	YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058.
[9]	LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078.
[10]	LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999.
[11]	LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088.
[12]	XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071.
[13]	RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960.
[14]	ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949.
[15]	ZHAO Xiaoqing, GUO Tongtong, ZHANG Xinyi, LI Linhong, ZHANG Ya, JI Lihong, DONG Zhiwei, GAO Qianqian, CAI Weiqing, ZHENG Wengui, JING Qi. Construction and Validation of a Risk Prediction Model for Cognitive Impairment in Community-dwelling Older Adults [J]. Chinese General Practice, 2025, 28(22): 2776-2783.